Similarly, in a complementary analysis exploring clinical data from TCGA, we determined that greater than 35% of a total of 517 NSCLC adenocarcinoma patients expressed elevated PTGR1 transcript levels (Figure 6B). Here, PTGR1 is linked to adenocarcinoma.